Drugmakers GSK Plc and Boehringer Ingelheim GmbH prioritized profits over consumer safety by hiding the cancer risks of their once-blockbuster heartburn drug Zantac, according to lawyers representing a Chicago woman in the first of thousands of such claims to go …
Sanofi will pay more than $100 million to settle about 4,000 lawsuits accusing the French drugmaker of failing to warn users that its Zantac heartburn medicine could cause cancer, according to people familiar with the deal. The settlement was announced …
Sanofi SA said it has agreed to settle approximately 4,000 lawsuits accusing the French drugmaker of selling its Zantac heartburn medicine without warning patients that it could cause cancer. The pact, the first major resolution of cases related to the …
GSK Plc settled a US lawsuit set to start in California over the UK drugmaker’s blockbuster heartburn medication Zantac, the second such agreement this month. The company said it had reached a confidential settlement with claimants listed as Boyd/Steenvoord, resolving …
GSK Plc has settled a US lawsuit on heartburn medicine Zantac just weeks before the case was due to be heard in a court in California. The British drugmaker said it had reached a confidential settlement with David Browne and …
The first scheduled trial over claims that GSK Plc’s heartburn drug Zantac caused cancer, which had been set to begin Monday, has been postponed by five months. The case, brought by California resident James Goetz in Alameda County Superior Court, …
Lawyers for a man who alleges he developed bladder cancer after taking GSK Plc’s heartburn drug Zantac urged a California judge on Thursday to allow expert testimony linking the drug to the illness at an upcoming trial. The trial in …
The plaintiff in the first lawsuit over the heartburn drug Zantac scheduled to go to trial has agreed to drop his case, according to his attorney and drugmakers named as defendants. Tuesday’s news came days after shares of GlaxoSmithKline Plc …
The plaintiff in the first lawsuit over the heartburn drug Zantac scheduled to go to trial has agreed to drop his case, according to his attorney and drugmakers named as defendants. The news on Tuesday came days after shares of …
Some generic Zantac is being pulled from major chain pharmacies in the U.S. shortly after French officials recalled all versions of the popular stomach drug amid a global investigation into a carcinogen found in the pills. Canadian drugmaker Apotex Inc. …